MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
37 hedge funds and large institutions have $14.1M invested in Merrimack Pharmaceuticals, Inc. in 2020 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 12 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
83% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 12
Holders
37
Holding in Top 10
–
Calls
$58K
Puts
$55K
Top Sellers
| 1 | -$337K | |
| 2 | -$160K | |
| 3 | -$139K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$133K |
| 5 |
Renaissance Technologies
New York
|
-$107K |